This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: University of Pittsburgh. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: Chuan Chen: Innovator in SARS-CoV-2 Research
Introduction
Chuan Chen is a notable inventor based in Pittsburgh, PA, who has made significant contributions to the field of biomedical research. His work primarily focuses on developing innovative solutions to combat viral infections, particularly those caused by SARS-CoV-2.
Latest Patents
Chuan Chen holds a patent for "Molecules that bind to SARS-CoV-2." This patent outlines methods and materials involved in binding a binder, such as an antibody or antigen binding fragment, to a SARS-CoV-2 antigen. The document details binders that can attach to a SARS-CoV-2 polypeptide and describes methods for using these binding molecules to treat mammals, including humans, suffering from COVID-19 or related viral infections. He has 1 patent to his name.
Career Highlights
Chuan Chen is affiliated with the University of Pittsburgh, where he conducts his research and contributes to the academic community. His work is pivotal in the ongoing fight against COVID-19, showcasing his commitment to public health and scientific advancement.
Collaborations
Chuan has collaborated with esteemed colleagues such as Dimiter Stanchev Dimitrov and Dontcho V Jelev, further enhancing the impact of his research through teamwork and shared expertise.
Conclusion
Chuan Chen's innovative work in developing binding molecules for SARS-CoV-2 represents a significant advancement in the fight against viral infections. His contributions are vital to the ongoing research efforts aimed at treating COVID-19 and improving public health outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile